Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI

Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Apr 13, 2026-

Reflow Medical announces 12-month results from DEEPER REVEAL trial

Spur stent system Reflow Medical has announced that 12-month results from the DEEPER REVEAL clinical trial were presented for the first time at the Society of Interventional Radiology (SIR) annual scientific meeting (11–15 April, Toronto, Canada). The data were presented by Constantino Peña (Miami Cardiac and Vascular Institute at Baptist Hospital, Miami, Florida) on behalf of the study’s principal investigators, Mahmood K Razavi (St Joseph Hear…

Reflow’s Spur Stent System Evaluated for CLTI in 12-Month DEEPER REVEAL Data

April 13, 2026—Reflow Medical, Inc. announced 12-month results from the DEEPER REVEAL clinical trial. According to the company, the prospective nonrandomized, multicenter study is evaluating the company’s Spur peripheral retrievable stent system after predilatation in patients with chronic limb-threatening ischemia (CLTI) and below-the-knee (BTK) arterial disease. The DEEPER REVEAL trial enrolled 130 patients at 49 centers in the United States. …